Logo image of KSCP

KNIGHTSCOPE INC-A (KSCP) Stock Fundamental Analysis

NASDAQ:KSCP - Nasdaq - US49907V2016 - Common Stock - Currency: USD

5.93  +0.31 (+5.52%)

After market: 5.97 +0.04 (+0.67%)

Fundamental Rating

3

Overall KSCP gets a fundamental rating of 3 out of 10. We evaluated KSCP against 84 industry peers in the Commercial Services & Supplies industry. While KSCP seems to be doing ok healthwise, there are quite some concerns on its profitability. KSCP is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

KSCP had negative earnings in the past year.
KSCP had a negative operating cash flow in the past year.
KSCP had negative earnings in each of the past 5 years.
KSCP had a negative operating cash flow in each of the past 5 years.
KSCP Yearly Net Income VS EBIT VS OCF VS FCFKSCP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 -10M -20M -30M -40M

1.2 Ratios

KSCP's Return On Assets of -104.12% is on the low side compared to the rest of the industry. KSCP is outperformed by 90.48% of its industry peers.
KSCP has a Return On Equity of -170.89%. This is amonst the worse of the industry: KSCP underperforms 82.14% of its industry peers.
Industry RankSector Rank
ROA -104.12%
ROE -170.89%
ROIC N/A
ROA(3y)-108.33%
ROA(5y)-145.46%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
KSCP Yearly ROA, ROE, ROICKSCP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 500 1K 1.5K

1.3 Margins

KSCP does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
KSCP Yearly Profit, Operating, Gross MarginsKSCP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 -200 -400 -600 -800 -1K

More info and screens

5

2. Health

2.1 Basic Checks

KSCP does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for KSCP has been reduced compared to 1 year ago.
KSCP has less shares outstanding than it did 5 years ago.
KSCP has a worse debt/assets ratio than last year.
KSCP Yearly Shares OutstandingKSCP Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
KSCP Yearly Total Debt VS Total AssetsKSCP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

2.2 Solvency

Based on the Altman-Z score of -9.24, we must say that KSCP is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -9.24, KSCP is doing worse than 85.71% of the companies in the same industry.
KSCP has a Debt/Equity ratio of 0.23. This is a healthy value indicating a solid balance between debt and equity.
KSCP has a better Debt to Equity ratio (0.23) than 71.43% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF N/A
Altman-Z -9.24
ROIC/WACCN/A
WACC8.56%
KSCP Yearly LT Debt VS Equity VS FCFKSCP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M -20M

2.3 Liquidity

A Current Ratio of 2.27 indicates that KSCP has no problem at all paying its short term obligations.
KSCP has a Current ratio of 2.27. This is in the better half of the industry: KSCP outperforms 76.19% of its industry peers.
KSCP has a Quick Ratio of 2.06. This indicates that KSCP is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of KSCP (2.06) is better than 83.33% of its industry peers.
Industry RankSector Rank
Current Ratio 2.27
Quick Ratio 2.06
KSCP Yearly Current Assets VS Current LiabilitesKSCP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

6

3. Growth

3.1 Past

KSCP shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 52.12%, which is quite impressive.
Looking at the last year, KSCP shows a decrease in Revenue. The Revenue has decreased by -5.62% in the last year.
Measured over the past years, KSCP shows a very strong growth in Revenue. The Revenue has been growing by 28.95% on average per year.
EPS 1Y (TTM)52.12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%68%
Revenue 1Y (TTM)-5.62%
Revenue growth 3Y46.88%
Revenue growth 5Y28.95%
Sales Q2Q%29.41%

3.2 Future

KSCP is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 27.09% yearly.
Based on estimates for the next years, KSCP will show a very strong growth in Revenue. The Revenue will grow by 27.51% on average per year.
EPS Next Y54.73%
EPS Next 2Y27.09%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year16.96%
Revenue Next 2Y27.51%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
KSCP Yearly Revenue VS EstimatesKSCP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 5M 10M 15M
KSCP Yearly EPS VS EstimatesKSCP Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 -5 -10 -15

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for KSCP. In the last year negative earnings were reported.
Also next year KSCP is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
KSCP Price Earnings VS Forward Price EarningsKSCP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
KSCP Per share dataKSCP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 -4 -6 -8

4.3 Compensation for Growth

KSCP's earnings are expected to grow with 27.09% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y27.09%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for KSCP!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

KNIGHTSCOPE INC-A

NASDAQ:KSCP (8/8/2025, 6:11:55 PM)

After market: 5.97 +0.04 (+0.67%)

5.93

+0.31 (+5.52%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)05-14 2025-05-14/amc
Earnings (Next)08-14 2025-08-14
Inst Owners13.23%
Inst Owner Change-2.27%
Ins Owners0.33%
Ins Owner Change0%
Market Cap50.52M
Analysts82.22
Price Target15.98 (169.48%)
Short Float %9.71%
Short Ratio1.22
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)35.4%
Min EPS beat(2)10.15%
Max EPS beat(2)60.65%
EPS beat(4)3
Avg EPS beat(4)8.09%
Min EPS beat(4)-40.39%
Max EPS beat(4)60.65%
EPS beat(8)4
Avg EPS beat(8)-0.48%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)12.09%
Min Revenue beat(2)9.12%
Max Revenue beat(2)15.07%
Revenue beat(4)3
Avg Revenue beat(4)18.31%
Min Revenue beat(4)-7.95%
Max Revenue beat(4)57.01%
Revenue beat(8)6
Avg Revenue beat(8)10.01%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-11.32%
EPS NQ rev (1m)0%
EPS NQ rev (3m)25.44%
EPS NY rev (1m)0%
EPS NY rev (3m)27.08%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-11.78%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-8.56%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 4.41
P/FCF N/A
P/OCF N/A
P/B 2.78
P/tB 3.35
EV/EBITDA N/A
EPS(TTM)-8.14
EYN/A
EPS(NY)-4.18
Fwd EYN/A
FCF(TTM)-2.38
FCFYN/A
OCF(TTM)-2.37
OCFYN/A
SpS1.35
BVpS2.13
TBVpS1.77
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -104.12%
ROE -170.89%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-108.33%
ROA(5y)-145.46%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.27
Quick Ratio 2.06
Altman-Z -9.24
F-Score5
WACC8.56%
ROIC/WACCN/A
Cap/Depr(3y)9.14%
Cap/Depr(5y)7.03%
Cap/Sales(3y)1.97%
Cap/Sales(5y)1.89%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)52.12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%68%
EPS Next Y54.73%
EPS Next 2Y27.09%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-5.62%
Revenue growth 3Y46.88%
Revenue growth 5Y28.95%
Sales Q2Q%29.41%
Revenue Next Year16.96%
Revenue Next 2Y27.51%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y0.32%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year23.67%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y10.75%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y8.89%
OCF growth 3YN/A
OCF growth 5YN/A